Saffron

Saffron — the crimson threads harvested from a purple crocus flower — is best known as the world's priciest spice, but it has drawn real scientific attention for one thing in particular: lifting low mood. Among all the herbal options marketed for depression, saffron stands out for having an unusually strong (though still limited) body of human trial evidence behind it, with several randomized controlled trials and meta-analyses pointing in the same direction. This page walks through what saffron is, where the evidence is genuinely solid (mild-to-moderate depression) versus still early (anxiety, PMS, eye health), how it's used, and the safety points that matter — including what the trials did not test, such as serious depression.

What Saffron Is
Depression & Mood — the Strongest Evidence
Other Studied Uses
How to Use It
Safety & Cautions
The Bottom Line
Key Research Papers
Connections
Featured Videos

What Saffron Is

Saffron is the dried red stigmas — the tiny thread-like parts that catch pollen — of the flower Crocus sativus. Each flower produces only three of these threads, and they must be plucked by hand. It takes roughly 150 flowers to yield a single gram of saffron, which is why it is, by weight, the most expensive spice in the world. A little goes a long way: a pinch is enough to color and flavor an entire pot of rice.

Beyond the kitchen, saffron has a long medicinal history. It appears in Persian, Greek, and other traditional medical systems going back thousands of years, where it was used for everything from low spirits to digestive and menstrual complaints. Modern researchers have since identified the plant compounds thought to be responsible for its color, aroma, and biological activity:

Crocin — the carotenoid pigment that gives saffron (and the food it's cooked in) its deep golden-red color. It's an antioxidant and is studied for effects on mood and the brain.
Safranal — the compound mainly responsible for saffron's distinctive aroma, also studied for calming and antioxidant effects.
Crocetin — a smaller carotenoid related to crocin, of interest for the eyes and circulation.
Picrocrocin — the compound behind saffron's slightly bitter taste.

Most of the clinical research uses a standardized extract — a preparation made to contain a consistent amount of these active compounds — rather than loose threads from a jar, which is worth keeping in mind when comparing the studies to what's on a store shelf.

Depression & Mood — the Strongest Evidence

If saffron has a flagship use, this is it. Several randomized controlled trials (the gold-standard study design, where people are assigned by chance to saffron, placebo, or a comparison drug) have tested standardized saffron extract in adults with mild-to-moderate depression, and the results have been consistently encouraging.

In two early trials from Iran, saffron 30 mg per day worked better than a placebo and performed about as well as standard antidepressants — fluoxetine in one trial and imipramine in another — over roughly six weeks. Later meta-analyses, which pool many trials together, reached a similar conclusion: saffron clearly beat placebo for depressive symptoms, and head-to-head it looked broadly comparable to low-dose antidepressants in the trials available.

That sounds impressive, and it is genuinely better evidence than most herbs can claim. But honesty about the limits matters just as much as the headline:

The trials are mostly small — often a few dozen people each — so the findings, while consistent, rest on modest numbers.
Most were conducted in a single country (Iran, often by overlapping research groups). Reviewers have specifically flagged this lack of geographic diversity, along with signs of publication bias, as reasons to stay cautious.
They were short — typically six to eight weeks — so we know little about saffron's effects over many months.
They studied mild-to-moderate depression, not severe depression, and used standardized extracts rather than culinary saffron.

The bottom line for mood: the trials tested saffron in mild-to-moderate depression, against placebo or against an antidepressant; they did not test it as a replacement for an antidepressant a person already takes, or in severe depression. A safety fact for anyone thinking of switching: the U.S. label for the antidepressant fluoxetine describes discontinuation reactions with this class of drugs, particularly when they are stopped abruptly — irritability, dizziness, electric-shock sensations, anxiety and insomnia among them — and recommends a gradual dose reduction rather than abrupt stopping whenever possible.

Other Studied Uses

Saffron has been explored for several other conditions. The evidence here is thinner than for depression — promising in places, but not yet proven. The following are "worth watching," not "established."

Anxiety

Some of the same trials and meta-analyses that looked at mood also measured anxiety symptoms, and saffron generally came out ahead of placebo. This often travels alongside its mood effect, which makes biological sense, but the dedicated anxiety evidence is still early and smaller than the depression data.

Premenstrual syndrome (PMS)

A randomized, placebo-controlled trial found that saffron 30 mg per day reduced the emotional and physical symptoms of PMS over two menstrual cycles. It's a single, fairly small study, so it's encouraging rather than definitive — but it points in a hopeful direction for cyclical mood and PMS-related symptoms.

Age-related macular degeneration (AMD)

Age-related macular degeneration is a common cause of central vision loss with age. A handful of small studies — using around 20 mg of saffron per day — reported measurable short-term improvements in retinal function (how well the light-sensing cells respond) in people with early age-related macular degeneration. This is intriguing and biologically plausible given saffron's antioxidant carotenoids, but the studies are small and short, and saffron is not a proven treatment for age-related macular degeneration. The U.S. National Eye Institute lists straight lines that start to look wavy as a warning sign of late age-related macular degeneration, one it treats as a reason to see an eye doctor right away, and notes that treatments are available for the faster-progressing wet form.

Where the evidence is weak

Saffron is sometimes marketed for weight loss or appetite/snacking control. The evidence for these claims is weak and insufficient. Other uses (memory, sexual function, blood sugar) have early laboratory or small-trial signals but are not established.

How to Use It

In the kitchen: a pinch of saffron threads — steeped briefly in a little warm water, milk, or broth to release the color and flavor — is enough to season a dish for several people. Culinary amounts are about flavor and enjoyment, not a clinical dose, but they're a safe, pleasant way to include it.

As a supplement: the mood, PMS, and anxiety trials most often used about 30 mg per day of a standardized saffron extract (frequently split as 15 mg twice daily); the eye studies used around 20 mg per day. "Standardized" means the product is made to deliver a consistent amount of the active compounds (such as crocin and safranal) in every dose — which is what the studies tested.

Quality and adulteration are a genuine problem. Because saffron is so valuable, it is one of the most adulterated spices in the world — commonly bulked out or faked with dyed corn silk, safflower, marigold petals, or other plant material, and sometimes cut with coloring agents. For both cooking and supplements, the practical facts are:

Real saffron is expensive because of the hand harvest described above, so saffron priced far below the norm is more likely to be bulked out or fake.
The research tested standardized extracts; published sourcing and third-party testing are the ways a supplement's contents can be checked against what the research studied.
Whole threads are harder to fake convincingly than pre-ground powder, which is more easily diluted.

Safety & Cautions

At the amounts used in cooking and at the doses studied in trials (around 30 mg per day), saffron has a good safety record, with side effects in studies generally mild and similar to placebo. That said, "natural" does not mean "harmless at any dose," and a few points deserve real attention:

Very high doses are toxic. Saffron is safe in normal use, but consuming it in the range of several grams at once (far, far beyond any culinary or supplement amount) can cause serious poisoning. The studied supplement doses, around 30 mg a day, are far below these gram amounts.
Pregnancy and high doses. Saffron has traditionally been regarded as a uterine stimulant and, at high doses, a possible abortifacient. A 2017 toxicology review (Bostan 2017) reports that in a case-control study of pregnant women who harvested saffron, the miscarriage rate was significantly higher among those exposed to high levels of saffron, possibly through uterine contraction and/or bleeding caused by saffron; citing too few safety trials in pregnancy, the review's authors suggest that pregnant women avoid high doses. A pinch in food is a different matter from concentrated supplements.
Possible interactions with antidepressants. Because saffron appears to affect mood-related brain chemistry, additive effects with prescription antidepressants (such as selective serotonin reuptake inhibitors (SSRIs)) are a theoretical concern. Two small 4-week placebo-controlled trials (2012 and 2013) added saffron, about 30 mg a day, for people whose depression was stable on the SSRI fluoxetine, to treat fluoxetine-related sexual problems; side effects were as frequent as with placebo.
Possible interaction with blood thinners. Saffron is suspected of mild blood-thinning/antiplatelet effects, which is why anticoagulant or antiplatelet medication and surgery come up in this context. In a one-week placebo-controlled trial described in the Bostan 2017 review, saffron tablets of 200 and 400 mg a day showed no adverse effect on the blood-clotting system.
Allergy. Allergic reactions are uncommon but possible, particularly in people sensitive to related plants.

None of the trials cited on this page was a study of breastfeeding women.

The Bottom Line

Among the many herbs promoted for low mood, saffron is one of the few with genuinely respectable human trial evidence behind it. Multiple randomized trials and meta-analyses agree that standardized saffron extract, around 30 mg a day, helps relieve mild-to-moderate depression — in some trials about as well as low-dose prescription antidepressants — and it may also help anxiety and PMS symptoms.

The honest caveats are real: most trials are small, short, and from a single region, so the evidence is encouraging rather than conclusive. The trials tested saffron for mild-to-moderate low mood, not as a cure-all and not as a replacement for treatment of serious depression. They used standardized products, and saffron is among the most counterfeited spices on the market.

Key Research Papers

The studies below are the most relevant real, peer-reviewed sources behind this page; each links to the original publication. Saffron's depression evidence is the strongest, but note the recurring caveats the authors themselves raise — small trials, limited geographic diversity, and signs of publication bias.

Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. 2013;11(6):377-383. — Pooled trials show saffron clearly beats placebo for depression and performs similarly to standard antidepressants; authors call for larger, international, longer studies. — doi:10.3736/jintegrmed2013056
Marx W, Lane M, Rocks T, et al. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutr Rev. 2019;77(8):557-571. — Across 23 studies saffron had positive effects on both depression and anxiety symptoms — but the authors flag publication bias and lack of regional diversity, urging caution. — doi:10.1093/nutrit/nuz023
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol. 2005;97(2):281-284. — Over six weeks, saffron 30 mg/day worked about as well as the antidepressant fluoxetine for mild-to-moderate depression — a small pilot trial. — doi:10.1016/j.jep.2004.11.004
Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res. 2005;19(2):148-151. — Saffron 30 mg/day significantly outperformed placebo on a standard depression rating scale, with side effects no different from placebo. — doi:10.1002/ptr.1647
Agha-Hosseini M, Kashani L, Aleyaseen A, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG. 2008;115(4):515-519. — Saffron 30 mg/day eased PMS symptoms more than placebo over two menstrual cycles — a single, small but well-designed trial. — doi:10.1111/j.1471-0528.2007.01652.x
Falsini B, Piccardi M, Minnella A, et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(12):6118-6124. — Short-term saffron (~20 mg/day) measurably improved retinal function in early AMD — a small, preliminary study, not proof saffron treats AMD. — doi:10.1167/iovs.09-4995
Bostan HB, Mehri S, Hosseinzadeh H. Toxicology effects of saffron and its constituents: a review. Iran J Basic Med Sci. 2017;20(2):110-121. — Reviews animal and human safety data, including a higher miscarriage rate among pregnant saffron harvesters exposed to high levels and no adverse effect on blood clotting from one week of 200–400 mg/day tablets. — PubMed PMID: 28293386
Modabbernia A, Sohrabi H, Nasehi AA, et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2012;223(4):381-388. — Saffron 15 mg twice daily, added for four weeks in men stable on fluoxetine; side effects were similar to placebo. — PubMed PMID: 22552758
Kashani L, Raisi F, Saroukhani S, et al. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. Hum Psychopharmacol. 2013;28(1):54-60. — Saffron 30 mg/day, added for four weeks in women stable on fluoxetine; side effects were similar to placebo. — PubMed PMID: 23280545